Jump to content

Yield10 Bioscience

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Bpierce1 (talk | contribs) at 16:53, 25 February 2013 (References: Replaced broken link Jewell article with similar subject matter article). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

Metabolix, Inc.
NasdaqMBLX
IndustrySpecialty Chemicals
Headquarters
Cambridge, MA
,
USA
Key people
Richard P. Eno (CEO), Anthony J. Sinskey (Founder), Joseph D. Hill (CFO), Oliver P. Peoples (CSO)
Revenue
  • IncreaseUS$1,425,000 (2011)
  • US$448,000 (2010)
  • IncreaseUS$-38,861,000 (2011)
  • US$-38,939,000 (2010)
  • IncreaseUS$-38,785,000 (2011)
  • US$-38,803,000 (2010)
OwnerFidelity Investments, Jack Schuler, State Farm Insurance, others
Number of employees
119
Websitewww.yield10bio.com Edit this on Wikidata

Metabolix is a bioplastics technology development and commercialization company. It is a spinoff of the University of Massachusetts Lowell

Joint Venture

On January 13, 2012 ADM announced that it was scrapping the joint venture. Metabolix's stock plunged 56% to $2.64 immediately following this announcement,[1] leading to a class action suit.

Lawsuit

Following the collapse of the Telles joint venture, shareholders of Metabolix filed a class-action lawsuit claiming that executives knowingly misled them about the viability of the production process of Mirel. The case, Coyne et al v. Metabolix, Inc., was filed on February 17, 2012 in Boston's federal court, citing Section 12(a)(2) of the Securities Act of 1933. It names executives Eno and Hill in addition to Metabolix. [2][3]

Notes

  1. ^ Lad 2012.
  2. ^ Block & Leviton LLP Files Securities Class Action Against Metabolix, Inc. 2012.
  3. ^ Coyne et al v. Metabolix, Inc. 2012.

References

  • "Block & Leviton LLP Files Securities Class Action Against Metabolix, Inc". Reuters. Boston. 2012-03-27. Retrieved 2012-10-04.
  • "Coyne et al v. Metabolix, Inc". Justia Dockets & Filings. Retrieved 2012-10-04.
  • Jewell, Mark (2007-10-19). "Makers of emerging plant-based plastics hope to carve larger market niche". Associated Press Archive. Retrieved 2013-02-25.
  • Jewell, Mark (2007-10-22). "'Bioplastics' carve niche in market". The Salt Lake City Tribune. Retrieved 2013-02-25.
  • Hovanesian, Mara Der (2008-08-13). "I Have Just One Word for You: Bioplastics". BusinessWeek: magazine. Retrieved 2012-10-04.
  • Lad, Divya (2012-01-13). "Metabolix hits life low as joint venture partner exits". Reuters. Bangalore. Retrieved 2013-02-25.
  • LaMonica, Martin (2008-08-11). "Metabolix grows bioplastics in switchgrass". CNET. Retrieved 2012-10-04.
  • Montenegro, Maywa (2009-11-10). "Bioplastics Man". Seed Magazine. Retrieved 2012-10-04.
  • Szaniszlo, Marie (2012-02-22). "Bioplastics firm sued after major deal fails". Boston Herald (ALL ed.). p. 23. ISSN 0738-5854. Retrieved 2012-10-04.